12:00 AM
 | 
Feb 12, 2015
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: K-Ras (KRAS); son of sevenless homolog 1 (SOS1)

Cancer

INDICATION: Cancer

In vitro studies have identified stapled peptide-based inhibitors of KRAS that could help treat cancer. In a KRAS binding assay, a stapled peptide based on the α-helix of SOS1 bound wild-type and...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >